Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetes Mellitus, Type 2 | 23 | 2025 | 12240 | 1.070 |
Why?
|
Diabetes Mellitus, Type 1 | 11 | 2025 | 3446 | 0.890 |
Why?
|
Diabetic Nephropathies | 3 | 2024 | 969 | 0.750 |
Why?
|
Diabetic Angiopathies | 4 | 2019 | 805 | 0.690 |
Why?
|
Glomerular Filtration Rate | 5 | 2024 | 2233 | 0.620 |
Why?
|
Blood Glucose | 5 | 2024 | 6424 | 0.620 |
Why?
|
Hypoglycemic Agents | 3 | 2024 | 3110 | 0.550 |
Why?
|
Fenofibrate | 4 | 2020 | 87 | 0.510 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2017 | 373 | 0.470 |
Why?
|
Polymorphism, Single Nucleotide | 11 | 2024 | 16047 | 0.410 |
Why?
|
Coronary Disease | 2 | 2022 | 5912 | 0.350 |
Why?
|
Cardiovascular Diseases | 5 | 2022 | 15652 | 0.290 |
Why?
|
Diabetic Retinopathy | 3 | 2025 | 1299 | 0.240 |
Why?
|
Glutamate-Ammonia Ligase | 3 | 2024 | 76 | 0.220 |
Why?
|
Uridine | 1 | 2022 | 135 | 0.200 |
Why?
|
Dyslipidemias | 2 | 2020 | 869 | 0.190 |
Why?
|
Receptor, Insulin | 1 | 2024 | 837 | 0.180 |
Why?
|
Retinal Neurons | 1 | 2021 | 67 | 0.180 |
Why?
|
Macular Edema | 1 | 2025 | 387 | 0.180 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2024 | 702 | 0.170 |
Why?
|
Gene Frequency | 2 | 2024 | 3624 | 0.170 |
Why?
|
Aryldialkylphosphatase | 1 | 2019 | 64 | 0.160 |
Why?
|
Kidney | 5 | 2024 | 7066 | 0.160 |
Why?
|
Cholesterol, HDL | 2 | 2019 | 1811 | 0.160 |
Why?
|
Genetic Predisposition to Disease | 6 | 2024 | 18071 | 0.160 |
Why?
|
Haptoglobins | 1 | 2020 | 166 | 0.160 |
Why?
|
Atherosclerosis | 3 | 2024 | 3424 | 0.160 |
Why?
|
Glutamic Acid | 1 | 2024 | 1180 | 0.160 |
Why?
|
Aortic Diseases | 1 | 2024 | 729 | 0.150 |
Why?
|
Carboxypeptidases A | 1 | 2018 | 27 | 0.150 |
Why?
|
PPAR alpha | 1 | 2020 | 175 | 0.150 |
Why?
|
Femur | 1 | 2024 | 1310 | 0.150 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2024 | 1499 | 0.150 |
Why?
|
Hypolipidemic Agents | 2 | 2020 | 608 | 0.150 |
Why?
|
Coronary Artery Disease | 4 | 2024 | 6544 | 0.150 |
Why?
|
Aldehyde Reductase | 1 | 2017 | 67 | 0.140 |
Why?
|
beta Karyopherins | 1 | 2017 | 46 | 0.140 |
Why?
|
Enzymes | 1 | 2019 | 254 | 0.140 |
Why?
|
Smad3 Protein | 1 | 2017 | 164 | 0.140 |
Why?
|
Pyruvate Kinase | 1 | 2019 | 192 | 0.140 |
Why?
|
Adipose Tissue, Brown | 1 | 2022 | 776 | 0.130 |
Why?
|
Diet, Reducing | 1 | 2019 | 487 | 0.130 |
Why?
|
Disease Progression | 5 | 2025 | 13632 | 0.130 |
Why?
|
Aged | 20 | 2025 | 171117 | 0.130 |
Why?
|
Risk Factors | 11 | 2024 | 74840 | 0.120 |
Why?
|
Metabolomics | 2 | 2022 | 1668 | 0.120 |
Why?
|
Diabetic Neuropathies | 1 | 2019 | 408 | 0.120 |
Why?
|
Retinal Vessels | 1 | 2021 | 863 | 0.120 |
Why?
|
Middle Aged | 22 | 2025 | 223009 | 0.120 |
Why?
|
Glucose | 2 | 2019 | 4335 | 0.120 |
Why?
|
Genotype | 3 | 2020 | 13024 | 0.120 |
Why?
|
Eye Proteins | 1 | 2018 | 628 | 0.120 |
Why?
|
Albuminuria | 2 | 2023 | 660 | 0.110 |
Why?
|
Periodontitis | 1 | 2019 | 576 | 0.110 |
Why?
|
Genetic Association Studies | 2 | 2024 | 2741 | 0.110 |
Why?
|
Plaque, Atherosclerotic | 1 | 2024 | 1529 | 0.110 |
Why?
|
Genome-Wide Association Study | 5 | 2019 | 12807 | 0.100 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2013 | 558 | 0.100 |
Why?
|
Genetic Markers | 1 | 2018 | 2601 | 0.100 |
Why?
|
Insulin-Secreting Cells | 1 | 2019 | 898 | 0.100 |
Why?
|
Male | 23 | 2025 | 363698 | 0.090 |
Why?
|
Endothelial Cells | 2 | 2022 | 3584 | 0.090 |
Why?
|
Metformin | 1 | 2018 | 904 | 0.090 |
Why?
|
Chromosomes, Human, Pair 9 | 1 | 2012 | 533 | 0.090 |
Why?
|
Humans | 32 | 2025 | 765968 | 0.090 |
Why?
|
Female | 22 | 2025 | 396112 | 0.080 |
Why?
|
Genetic Loci | 1 | 2019 | 2631 | 0.080 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1892 | 0.080 |
Why?
|
Prefrontal Cortex | 1 | 2019 | 2224 | 0.080 |
Why?
|
Cell Proliferation | 1 | 2024 | 10429 | 0.080 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22332 | 0.080 |
Why?
|
Insulin | 3 | 2024 | 6599 | 0.080 |
Why?
|
Apoptosis | 1 | 2024 | 9514 | 0.080 |
Why?
|
Cohort Studies | 7 | 2021 | 41649 | 0.080 |
Why?
|
Signal Transduction | 3 | 2024 | 23601 | 0.070 |
Why?
|
Weight Loss | 1 | 2019 | 2710 | 0.070 |
Why?
|
Apolipoproteins E | 2 | 2024 | 1458 | 0.070 |
Why?
|
Cognition | 2 | 2021 | 7049 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2495 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12509 | 0.060 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18293 | 0.060 |
Why?
|
gamma-Glutamylcyclotransferase | 1 | 2024 | 11 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39193 | 0.060 |
Why?
|
Models, Statistical | 1 | 2019 | 5089 | 0.060 |
Why?
|
Bone Matrix | 1 | 2024 | 126 | 0.060 |
Why?
|
Insulin Resistance | 2 | 2024 | 3985 | 0.060 |
Why?
|
Rupture, Spontaneous | 1 | 2024 | 359 | 0.060 |
Why?
|
Inflammation Mediators | 2 | 2024 | 1884 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10383 | 0.050 |
Why?
|
Thrombospondin 1 | 1 | 2024 | 256 | 0.050 |
Why?
|
Triglycerides | 1 | 2011 | 2441 | 0.050 |
Why?
|
Spectrum Analysis, Raman | 1 | 2024 | 252 | 0.050 |
Why?
|
Prospective Studies | 3 | 2022 | 54802 | 0.050 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2024 | 462 | 0.050 |
Why?
|
Receptor, IGF Type 1 | 1 | 2024 | 385 | 0.050 |
Why?
|
Homeostasis | 1 | 2013 | 3336 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2024 | 22223 | 0.050 |
Why?
|
Arginine | 1 | 2024 | 933 | 0.050 |
Why?
|
Pyruvaldehyde | 1 | 2020 | 16 | 0.040 |
Why?
|
Necrosis | 1 | 2024 | 1617 | 0.040 |
Why?
|
Retina | 2 | 2021 | 2657 | 0.040 |
Why?
|
Lysine | 1 | 2024 | 991 | 0.040 |
Why?
|
Dental Plaque Index | 1 | 2019 | 96 | 0.040 |
Why?
|
Glutamates | 1 | 2020 | 384 | 0.040 |
Why?
|
Periodontal Attachment Loss | 1 | 2019 | 151 | 0.040 |
Why?
|
Heart Failure | 1 | 2023 | 11840 | 0.040 |
Why?
|
HLA-A Antigens | 1 | 2019 | 223 | 0.040 |
Why?
|
Glucose Clamp Technique | 1 | 2019 | 262 | 0.040 |
Why?
|
Dipeptides | 1 | 2020 | 387 | 0.040 |
Why?
|
Adult | 6 | 2024 | 223044 | 0.040 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2019 | 313 | 0.040 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2020 | 640 | 0.040 |
Why?
|
Capillaries | 1 | 2021 | 755 | 0.040 |
Why?
|
Appetite | 1 | 2019 | 247 | 0.040 |
Why?
|
Risk Assessment | 4 | 2024 | 24282 | 0.040 |
Why?
|
Phenotype | 3 | 2024 | 16721 | 0.040 |
Why?
|
Endophthalmitis | 1 | 2020 | 263 | 0.040 |
Why?
|
C-Peptide | 1 | 2019 | 443 | 0.040 |
Why?
|
Glutamine | 1 | 2020 | 576 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2024 | 1727 | 0.030 |
Why?
|
Aorta | 1 | 2024 | 2028 | 0.030 |
Why?
|
Kidney Glomerulus | 1 | 2019 | 568 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2019 | 591 | 0.030 |
Why?
|
Simvastatin | 1 | 2018 | 345 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2024 | 2453 | 0.030 |
Why?
|
Angiography | 1 | 2021 | 1581 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2020 | 682 | 0.030 |
Why?
|
Chemokines | 1 | 2020 | 956 | 0.030 |
Why?
|
Time Factors | 3 | 2024 | 40065 | 0.030 |
Why?
|
Proteomics | 2 | 2019 | 3910 | 0.030 |
Why?
|
Autopsy | 1 | 2019 | 1011 | 0.030 |
Why?
|
Lipoproteins | 1 | 2019 | 866 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2019 | 798 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 26318 | 0.030 |
Why?
|
Longevity | 1 | 2021 | 1087 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 870 | 0.030 |
Why?
|
Blood Proteins | 1 | 2019 | 1188 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2018 | 618 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2022 | 2143 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2019 | 2352 | 0.030 |
Why?
|
Pyrophosphatases | 1 | 2013 | 141 | 0.030 |
Why?
|
Databases, Genetic | 1 | 2019 | 1751 | 0.020 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2013 | 204 | 0.020 |
Why?
|
Bone Density | 1 | 2024 | 3491 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2020 | 3421 | 0.020 |
Why?
|
Heart | 1 | 2024 | 4414 | 0.020 |
Why?
|
Mice | 3 | 2024 | 81819 | 0.020 |
Why?
|
Autoantibodies | 1 | 2019 | 2113 | 0.020 |
Why?
|
Health Behavior | 1 | 2021 | 2650 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2024 | 18973 | 0.020 |
Why?
|
Italy | 1 | 2011 | 854 | 0.020 |
Why?
|
Lipids | 1 | 2020 | 3315 | 0.020 |
Why?
|
Prognosis | 2 | 2019 | 29922 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2021 | 12056 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6897 | 0.020 |
Why?
|
Tomography, Optical Coherence | 1 | 2021 | 2932 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2019 | 3212 | 0.020 |
Why?
|
Mitochondria | 1 | 2019 | 3673 | 0.020 |
Why?
|
Animals | 3 | 2024 | 168764 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 59489 | 0.020 |
Why?
|
Blood Pressure | 1 | 2020 | 8532 | 0.010 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2310 | 0.010 |
Why?
|
Cause of Death | 1 | 2015 | 3708 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2018 | 12437 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2013 | 2968 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 65188 | 0.010 |
Why?
|
Prevalence | 1 | 2019 | 15842 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3430 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9525 | 0.010 |
Why?
|
Incidence | 1 | 2019 | 21480 | 0.010 |
Why?
|
Odds Ratio | 1 | 2011 | 9649 | 0.010 |
Why?
|
Boston | 1 | 2011 | 9338 | 0.010 |
Why?
|
Obesity | 1 | 2019 | 13076 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13266 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 59889 | 0.010 |
Why?
|
Body Mass Index | 1 | 2011 | 13039 | 0.010 |
Why?
|
United States | 1 | 2021 | 72903 | 0.010 |
Why?
|
Child | 1 | 2019 | 80564 | 0.010 |
Why?
|
Adolescent | 1 | 2019 | 88835 | 0.010 |
Why?
|
Hypertension | 1 | 2011 | 8626 | 0.010 |
Why?
|
Concepts
(180)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_